Liometacen [As Meglumine Salt] en es it fr

Categoria

Liometacen [As Meglumine Salt] Nombres de marca, Liometacen [As Meglumine Salt] Analogos

Liometacen [As Meglumine Salt] Marca los nombres de mezcla

  • No information avaliable
  • Liometacen [As Meglumine Salt] Formula quimica

    C19H16ClNO4

    Liometacen [As Meglumine Salt] RX enlace

    http://www.rxlist.com/cgi/generic/indometh.htm

    Liometacen [As Meglumine Salt] FDA hoja

    Liometacen [As Meglumine Salt] MSDS (hoja de seguridad de materiales)

    Liometacen_[As_Meglumine_Salt] MSDS

    Liometacen [As Meglumine Salt] Sintesis de referencia

    No hay información disponible

    Liometacen [As Meglumine Salt] Peso molecular

    357.787 g/mol

    Liometacen [As Meglumine Salt] Punto de fusion

    158 oC

    Liometacen [As Meglumine Salt] H2O Solubilidad

    0,937 mg / L

    Liometacen [As Meglumine Salt] Estado

    Solid

    Liometacen [As Meglumine Salt] LogP

    3.655

    Liometacen [As Meglumine Salt] Formas de dosificacion

    Cápsula

    Liometacen [As Meglumine Salt] Indicacion

    De moderada a severa artritis reumatoide incluyendo brotes agudos de la enfermedad crónica, espondilitis anquilosante, artrosis, hombro doloroso agudo (bursitis y / o tendinitis) y la artritis gotosa aguda.

    Liometacen [As Meglumine Salt] Farmacologia

    Indometacina, un medicamento antiinflamatorio no esteroideo (AINE) con propiedades analgésicas y antipiréticas, se utiliza para tratar la osteoartritis y el control del dolor agudo.

    Liometacen [As Meglumine Salt] Absorcion

    No hay información disponible

    Liometacen [As Meglumine Salt] Toxicidad

    No hay información disponible

    Liometacen [As Meglumine Salt] Informacion de Pacientes

    Indomethacin, like other drugs of its class, is not free of side effects. The side effects of these drugs can cause discomfort and rarely, there are more serious side effects, such as gastrointestinal bleeding, which may result in hospitalization and even fatal outcomes. NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) are often essential agents in the management of arthritis, but they also may be commonly employed for conditions which are less serious. Physicians may wish to discuss with their patients the potential risks and likely benefits of NSAID treatment, particularly when the drugs are used for less serious conditions where treatment without NSAIDs may represent an acceptable alternative to both the patient and physician.

    Liometacen [As Meglumine Salt] Organismos afectados

    Humanos y otros mamíferos